Plain-English translation of NCT07036328 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS) — a non-invasive procedure that uses magnetic pulses to stimulate a specific brain region affected by Alzheimer's disease. Researchers believe this treatment may help slow down memory loss and cognitive decline. The study will compare real treatment to sham treatment (a placebo) to see if rTMS actually works.
Current Alzheimer's medications have limited effectiveness and can cause side effects. Recent early research suggested that this treatment might help keep cognitive abilities stable or even improve brain activity in people with Alzheimer's, so researchers want to test it more thoroughly in a larger group.
You likely qualify if…
You likely don't qualify if…
Participants will receive magnetic stimulation sessions targeting a specific brain region over 24 weeks. Half will receive real treatment and half will receive sham treatment (inactive stimulation), though neither participants nor researchers will know which group is which during the study. You will need brain imaging scans (MRI and MEG) and cognitive tests at various points during the trial, and you should have a caregiver available to support you throughout.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Netherlands